Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.41%16.63B | 7.44%10.78B | 47.31%3.42B | 9.61%12.66B | 77.08%16.7B | 79.13%10.04B | -30.18%2.32B | 0.96%11.55B | -35.12%9.43B | -41.04%5.6B |
| Refunds of taxes and levies | 83.18%369.7M | 1.17%168.63M | --19.33M | 13,672.11%259.23M | --201.83M | 8,757.29%166.68M | ---- | --1.88M | ---- | --1.88M |
| Cash received relating to other operating activities | -4.61%1.83B | -69.85%460.25M | -4.62%319.59M | 18.88%817.03M | 858.10%1.92B | 919.36%1.53B | 226.90%335.08M | -9.70%687.25M | -72.35%200.75M | -46.48%149.77M |
| Cash inflows from operating activities | 0.05%18.83B | -2.71%11.41B | 41.48%3.76B | 12.24%13.74B | 95.46%18.82B | 103.84%11.73B | -22.49%2.65B | 0.31%12.24B | -36.89%9.63B | -41.18%5.75B |
| Goods services cash paid | 12.09%11.19B | 40.22%7.72B | 119.46%3.05B | 41.14%10.91B | 60.94%9.98B | 57.80%5.51B | -26.82%1.39B | 36.12%7.73B | -37.70%6.2B | -47.90%3.49B |
| Staff behalf paid | -0.87%1.1B | 1.59%751.49M | 2.99%220.69M | 13.56%918.97M | 85.78%1.11B | 83.73%739.71M | -1.70%214.29M | 0.68%809.24M | 3.84%596.76M | 3.95%402.6M |
| All taxes paid | -22.52%1.14B | -14.71%804M | 88.69%95.92M | -30.61%366.29M | 260.15%1.47B | 204.22%942.68M | -57.07%50.84M | -48.00%527.85M | -49.50%409.14M | -48.69%309.87M |
| Cash paid relating to other operating activities | -24.81%2.28B | -64.52%844.8M | -59.94%280.71M | -49.70%777.27M | 295.11%3.04B | 399.33%2.38B | 195.55%700.68M | 83.08%1.55B | 23.04%769.02M | 11.63%476.82M |
| Cash outflows from operating activities | 0.72%15.72B | 5.77%10.12B | 54.79%3.64B | 22.23%12.97B | 95.59%15.6B | 104.52%9.57B | -4.71%2.35B | 27.22%10.61B | -33.33%7.98B | -42.35%4.68B |
| Net cash flows from operating activities | -3.16%3.12B | -40.35%1.29B | -62.66%112.35M | -52.86%768.22M | 94.84%3.22B | 100.87%2.16B | -68.48%300.86M | -57.80%1.63B | -49.82%1.65B | -35.45%1.07B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | 31.29%136M | 2,512.44%90.47M | 1,055.00%40M | --10.02M | -93.61%103.59M | -99.79%3.46M | -96.26%3.46M |
| Cash received from returns on investments | ---- | ---- | ---- | 628.26%18.34M | -87.12%324.33K | --88.07K | ---- | -98.25%2.52M | -98.16%2.52M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -38.71%272.99M | -39.79%267.96M | -98.63%4.18M | 118.70%561.04M | 88.52%445.44M | 88.95%445.05M | 133.33%305.8M | 587.22%256.53M | 558.39%236.29M | 1,578.95%235.53M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --150.16M | --150.16M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | --35M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -62.16%272.99M | -44.77%267.96M | -98.68%4.18M | 138.68%865.54M | 197.77%721.4M | 102.99%485.14M | 140.98%315.82M | -79.88%362.64M | -86.50%242.27M | 19.38%239M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -13.27%3.46B | 39.27%2.65B | 152.03%1.41B | 165.65%4.66B | 152.39%3.99B | 200.38%1.9B | 17.44%557.66M | -21.62%1.76B | 61.21%1.58B | 21.16%634.16M |
| Cash paid to acquire investments | -37.50%246.4M | -29.30%197.4M | -84.22%70M | -2.49%748.36M | 65.64%394.23M | 184.92%279.23M | 352.58%443.53M | -2.29%767.5M | -67.66%238M | -62.78%98M |
| Cash paid relating to other investing activities | -46.05%512.48K | --1.71M | ---- | ---- | --950K | ---- | ---- | -21.48%11.86M | ---- | ---- |
| Cash outflows from investing activities | -15.46%3.7B | 30.58%2.85B | 47.37%1.48B | 113.50%5.41B | 141.08%4.38B | 198.31%2.18B | 74.77%1B | -16.63%2.54B | 5.00%1.82B | -8.69%732.16M |
| Net cash flows from investing activities | 6.26%-3.43B | -52.10%-2.58B | -114.68%-1.47B | -109.30%-4.55B | -132.36%-3.66B | -244.51%-1.7B | -55.13%-685.37M | -75.47%-2.17B | -2,564.26%-1.57B | 18.02%-493.16M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -41.91%76.43M | --29.95M | --14.7M | -90.30%156.07M | -91.64%131.57M | ---- | ---- | 119.78%1.61B | 114.95%1.57B | -99.38%3.36M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 102.03%52.26M | --29.95M | --14.7M | 37.26%50.37M | 669.85%25.87M | ---- | ---- | -94.99%36.69M | -99.54%3.36M | -99.38%3.36M |
| Cash from borrowing | -12.45%9.89B | -22.40%6.44B | -32.18%1.57B | 181.98%10.25B | 327.33%11.3B | 467.62%8.3B | 255.66%2.31B | -46.02%3.64B | -33.02%2.64B | -47.14%1.46B |
| Cash received relating to other financing activities | -93.05%125.66M | -80.96%125.66M | -38.69%122.61M | 169.53%648.65M | 318.21%1.81B | 93.20%660M | -10.29%200M | -53.15%240.66M | -15.88%432.08M | -33.49%341.62M |
| Cash inflows from financing activities | -23.74%10.09B | -26.38%6.6B | -32.12%1.71B | 101.57%11.06B | 184.69%13.24B | 395.80%8.96B | 186.63%2.51B | -31.27%5.49B | -10.47%4.65B | -52.69%1.81B |
| Borrowing repayment | -5.75%8.21B | -27.46%4.55B | -15.10%1.13B | 21.65%5.73B | 182.63%8.71B | 260.70%6.27B | 89.76%1.33B | -48.56%4.71B | -51.14%3.08B | -46.62%1.74B |
| Dividend interest payment | -73.27%658.43M | -32.00%546.16M | 86.05%125.09M | 33.20%780.67M | 487.23%2.46B | 162.84%803.2M | -40.37%67.23M | -40.62%586.09M | -53.17%419.47M | -58.47%305.59M |
| -Including:Cash payments for dividends or profit to minority shareholders | -96.19%66.5M | --66.5M | 256.67%49M | 29.13%248.28M | 1,729.12%1.75B | ---- | -65.61%13.74M | -70.05%192.27M | -84.68%95.44M | -92.70%39.41M |
| Cash payments relating to other financing activities | -8.03%3.26B | 53.24%1.68B | 3.46%22.25M | -30.25%281.38M | 539.66%3.54B | 28.97%1.09B | -92.97%21.51M | -47.67%403.42M | -7.73%553.64M | 11.18%848.95M |
| Cash outflows from financing activities | -17.60%12.12B | -17.09%6.77B | -10.03%1.28B | 19.16%6.79B | 262.89%14.71B | 182.34%8.17B | 26.77%1.42B | -47.78%5.7B | -48.03%4.05B | -39.17%2.89B |
| Net cash flows from financing activities | -37.41%-2.03B | -121.76%-173.1M | -60.85%427.33M | 2,071.87%4.26B | -348.49%-1.48B | 173.34%795.61M | 547.40%1.09B | 92.64%-216.2M | 122.79%594.71M | -16.10%-1.08B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -73.40%8.65M | -82.21%4.87M | 69.86%2.46M | 30,111.59%43.84M | 334.76%32.54M | 317.59%27.38M | 124.29%1.45M | -104.38%-146.09K | 97.99%7.48M | 147.00%6.56M |
| Net increase in cash and cash equivalents | -23.84%-2.34B | -214.32%-1.47B | -231.14%-929.19M | 169.57%528.24M | -377.63%-1.89B | 357.77%1.28B | 169.52%708.52M | -144.27%-759.27M | -9.44%679.29M | -480.13%-497.22M |
| Add:Begin period cash and cash equivalents | -22.25%5.09B | -22.25%5.09B | 23.27%2.8B | -25.06%2.27B | 116.12%6.55B | 116.12%6.55B | -24.98%2.27B | -9.21%3.03B | -9.21%3.03B | -9.21%3.03B |
| End period cash equivalent | -40.90%2.76B | -53.69%3.63B | -37.25%1.87B | 23.27%2.8B | 25.69%4.66B | 209.17%7.83B | -9.43%2.98B | -24.98%2.27B | -9.26%3.71B | -26.98%2.53B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.